A Teaching Model for Aromatase Inhibitors After Tamoxifen
- First Online:
- 50 Downloads
Breast cancer is the most common cancer diagnosed in women. The present study evaluated the family physicians' (FPs) understanding of adjuvant hormonal therapies for an early breast cancer. FPs were invited to attend teaching workshops on this topic, which utilized a pretest, didactic and interactive teaching, and posttest format. FPs (n = 23) showed an improvement (p < 0.001) in pretest to posttest score. It is clear that, with a targeted teaching, FPs can quickly become more knowledgeable on the topic of hormonal therapies in breast cancer, with the potential of applying this information in their own practice.
KeywordsTamoxifen Physician Aromatase inhibitors Teaching model Letrozole
- 6.Boccardo F, Rubagotti A, Guglielmini P, et al. (2006) Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian Tamoxifen Anastrozole Study (ITA) Trial. Ann Oncol 17 Suppl 7:vii10–vii14Google Scholar
- 7.Trotter T, Railton C, Webster M et al (2007) Acceptance of extended hormonal therapy with letrozole after 5 years of adjuvant tamoxifen in post-menopausal breast cancer patients. Abstract. Breast Cancer Res Treat 106(Suppl 1):S145Google Scholar
- 9.O’Brien MA, Freemantle N, Oxman AD, et al. (2001) Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev, Issue 1. Art. no.: CD002020. doi:10.1002/14651858.CD003030